Share This Article:

Oxidative Stress and Antioxidant Status in Acute and Chronic Myeloid Leukemia Patients

Abstract Full-Text HTML Download Download as PDF (Size:479KB) PP. 17-22
DOI: 10.4236/ojbd.2013.33A004    3,401 Downloads   6,391 Views   Citations

ABSTRACT

Oxidative stress, a pervasive condition of increased number of reactive oxygen species, is now recognized to be prominent feature of various diseases and their progression. The relationship between antioxidants and levels of well-known markers of oxidative stress, measured as lipid peroxides and oxidized proteins reflect health indices. The aim of this study is to evaluate the extent of oxidative stress and antioxidant status in acute and chronic myeloid leukemia patients. The present study included 60 patients selected using standard questionnaire based on age, family history, Body Mass Index (BMI), dietary intake, with no other complications and 30 age and sex-matched healthy subjects. The median age of myeloid leukemia patients was 43 years and that of controls was 42 years. Out of 60 myeloid leukemia patients, 30 were in acute and 30 were in chronic state. Oxidative stress and antioxidant status were evaluated in the patients and in the controls by assessing standard oxidative stress markers viz. plasma and erythrocyte lipid peroxide levels in terms of malondialdehyde and oxidized proteins as protein carbonyls whereas antioxidant status was assessed in terms of serum non enzymatic antioxidant levels. There was a significant increase (p < 0.01) in plasma and erythrocyte lipid peroxidation and protein oxidation in acute and chronic myeloid leukemia patients as compared to healthy subjects. Antioxidant status as indicated by the levels of non-enzymatic antioxidants viz. erythrocyte reduced glutathione (GSH), serum β carotene, vitamin A & C and ceruloplasmin was found to be significantly decreased (p < 0.01) in both the leukemia patients as compared to healthy participants. However, chronic myeloid leukemia patients had significantly (p < 0.05) higher oxidative stress and lower antioxidant status as compared to acute myeloid leukemia patients.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

U. Rajeshwari, I. Shobha, R. Raghunatha and B. Andallu, "Oxidative Stress and Antioxidant Status in Acute and Chronic Myeloid Leukemia Patients," Open Journal of Blood Diseases, Vol. 3 No. 3A, 2013, pp. 17-22. doi: 10.4236/ojbd.2013.33A004.

References

[1] B. Halliwell and J. M. C. Gutteridge, “Free Radicals in Biology and Medicine,” 3rd Edition, Oxford University Press, Oxford, 1999.
[2] B. Frei, “Reactive Oxygen Species and Antioxidant Vitamins: Mechanisms of Action,” The American Journal of Medicine, Vol. 97, No. 3, 1994, pp. S5-S13. http://dx.doi.org/10.1016/0002-9343(94)90292-5
[3] M. Irshad and P. S. Chaudhuri, “Oxidant-Antioxidant System: Role and Significance in Human Body,” Indian Journal of Experimental Biology, Vol. 40, No. 11, 2002, pp. 1233-1239.
[4] R. Dalle-Donne, R. Rossi, R. Colombo, D. Giustarini and A. Milazani, “Biomarkers of Oxidative Stress in Human Disease,” Clinical Chemistry, Vol. 52, No. 4, 2006, pp. 601-623. http://dx.doi.org/10.1373/clinchem.2005.061408
[5] F. Galli, M. Piroddi, C. Annetti, et al., “Oxidative Stress and Reactive Oxygen Species,” Contributions to Nephrology, Vol. 149, 2005, pp. 240-260. http://dx.doi.org/10.1159/000085686
[6] H. Uzun, D. Konukoglu, R. Gelisgen, K. Zengin and M. Taskin, “Plasma Protein Carbonyl and Thiol Stress before and after Laproscopic Gastric Banding in Morbidly Obese Patients,” Obesity Surgery, Vol. 17, No. 10, 2007, pp. 1367-1373. http://dx.doi.org/10.1007/s11695-007-9242-8
[7] S. Faderl, M. Talpaz, Z. Estrov, S. O’Brien, R. Kurzrock and H. M. Kantarjian, “The Biology of Chronic Myeloid Leukemia,” The New England Journal of Medicine, Vol. 341, 1999, pp. 164-172. http://dx.doi.org/10.1056/NEJM199907153410306
[8] G. S. Devi, M. H. Prasad, I. Saraswathi, D. Raghu, D. N. Rao and P. P. Reddy, “Free Radicals Antioxidant Enzymes and Lipid Peroxidation in Different Types of Leukemias,” Clinica Chimica Acta, Vol. 293, No. 1-2, 2000, pp. 53-62. http://dx.doi.org/10.1016/S0009-8981(99)00222-3
[9] J. Beuge and S. D. Aust, “Microsomal Lipid Peroxidation,” Methods in Enzymology, Academic Press, New York, 1978, pp. 302-316.
[10] J. Stocks and T. L. Dormandy, “The Antioxidative of Human Red Cell Lipids Induced by Hydrogen Peroxides,” British Journal of Haematology, Vol. 20, 1971, pp. 95-111. http://dx.doi.org/10.1111/j.1365-2141.1971.tb00790.x
[11] E. Beutler, O. Duron and B. M. Kelley, “Improved Method for the Determination of Blood Glutathione,” The Journal of Laboratory and Clinical Medicine, Vol. 61, 1963, pp. 882-890.
[12] R. L. Levine, D. Garland, C. N. Oliver, A. Amici, I. Climent, A. Lenz, B. Ahn, S. Shaltiel and E. R. Stadtman, “Determination of Carbonyl Content in Oxidatively Modified Proteins,” Methods in Enzymology, Vol. 186, 1990, pp. 464-478. http://dx.doi.org/10.1016/0076-6879(90)86141-H
[13] J. B. Henry, “Clinical Diagnosis and Management by Laboratory Methods,” 17th Edition, W.B Sounders Company, Philadelphia, 1984, pp. 505-589.
[14] J. H. Roe, “Standard Methods in Clinical Chemistry,” In: D. Seigson, Ed., Vol. 2, Academic Process, New York, 1961, p. 35.
[15] N. Raghuramulu, N. K. Madhavan and K. Sundarm, Eds., “A Manual of Laboratory Techniques,” NIN, Hyderabad, 1983, pp. 140-142,319-320.
[16] A. E. Hammouda, S. F. Soliman, K. A. Tolba, Z. A. El-Kabbany and M. S. Makhlouf, “Plasma Concentrations of Lipid Peroxidation Products in Children with Acute Lymphoblastic Leukemia,” Clinical Chemistry, Vol. 38, No. 4, 1992, pp. 594-595.
[17] R. K. Singh, A. K. Tripathi, P. Tripathi, S. Singh, R. Singh and R. Ahmad, “Studies on Biomarkers for Oxidative Stress in Patients with Chronic Myeloid Leukemia,” Hematology/Oncology and Stem Cell Therapy, Vol. 2, No. 1, 2009, pp. 285-288.
[18] R. Ahmad, A. K. Tripathi, P. Tripathi, R. Singh, S. Singh and R. K. Singh, “Studies on Lipid Peroxidation and Non-Enzymatic Antioxidant Status as Indices of Oxidative in Patients with Chronic Myeloid Leukemia,” Singapore Medical Journal, Vol. 51, No. 2, 2010, pp. 110-115.
[19] Y. Sun, “Free Radicals, Antioxidant Enzymes and Carcinogenesis,” Free Radical Biology & Medicine, Vol. 8, 1990, pp. 583-599. http://dx.doi.org/10.1016/0891-5849(90)90156-D
[20] G. Wu, Y. Z. Fang, S. Yang, J. R. Lupton and N. D. Turner, “Glutathione Metabolism and Its Implications for Health,” Journal of Nutrition, Vol. 134, No. 3, 2004, pp. 489-492.
[21] J. S. Giftson, S. Jayanthi and N. Nalini, “Chemopreventive Efficacy of Gallic Acid, an Antioxidant and Anticarcinogenic Polyphenol, against 1, 2-Dimethyl Hydrazine Induced Rat Colon Carcinogenesis,” Investigational New Drugs, Vol. 28, 2010, pp. 251-259.
[22] V. Sreedharan, K. K. Venkatachalam and N. Namasivayam, “Effect of Morin on Tissue Lipiperoxidation and Antioxidant Status in 1,2-Dimethylhydrazine Induced Experimental Colon Carcinogenesis,” Investigational New Drugs, Vol. 27, 2009, pp. 21-30.
[23] V. Sudhahar, S. A. Kumar, P. Varalakshmi and R. Sundarapandiyan, “Mitigating Role of Lupeol and Lupeol Linoleate on Hepatic Lipemic-Oxidative Injury and Lipoprotein Peroxidation in Experimental Hypercholesterolemia,” Molecular and Cellular Biochemistry, Vol. 295, No. 1-2, 2007, pp. 189-198. http://dx.doi.org/10.1007/s11010-006-9288-2
[24] C. H. Foyer and G. Noctor, “Oxidant and Antioxidant Signaling in Plants: A Re-Evaluation of the Concept of Oxidative Stress in a Physiological Context,” Plant, Cell and Environment, Vol. 28, 2005, pp. 1056-1071. http://dx.doi.org/10.1111/j.1365-3040.2005.01327.x
[25] V. Arulmozhi, M. Krishnaveni, K. Karthishwaran, G. Dhamodharan and S. Mirunalini, “Antioxidant and Antihy-perlipidemic Effect of Solanum nigrum Fruit Extract on the Experimental Model against Chronic Ethanol Toxicity,” Pharmacognosy Magazine, Vol. 6, No. 21, 2010, pp. 42-50. http://dx.doi.org/10.4103/0973-1296.59965
[26] P. Veeru, M. P. Kishor and M. Meenakshi, “Screening of Medicinal Plant Extracts for Antioxidant Activity,” Journal of Medicinal Plants Research, Vol. 3, 2009, pp. 608-612.
[27] S. Goto, K. Kogure, K. Abe, Y. Kimata, K. Kitahama, E. Yamashita and H. Terada, “Efficient Radical Trapping at the Surface and Inside the Phospholipid Membrane Is Responsible for Highly Potent Antiperoxidative Activity of the Carotenoid Astaxanthin,” Biochimica et Biophysica Acta, Vol. 1512, No. 2, 2001, pp. 251-258. http://dx.doi.org/10.1016/S0005-2736(01)00326-1
[28] A. R. Collins and V. Harrington, “Antioxidants: Not the Only Reason to Eat Fruit and Vegetables,” Phytochemistry Reviews, Vol. 1, No. 2, 2002, pp. 167-174. http://dx.doi.org/10.1023/A:1022514432233
[29] S. B. Nissen, A. Tjonneland, C. Stripp, A. Olsen, J. Christensen, K. Overvad, L. O. Dragsted and B. Thomson, “Intake of Vitamin A, C and E from Diets and Supplements and Breast Cancer in Post Menopausal Women,” Cancer Causes Control, Vol. 14, No. 8, 2003, pp. 695-704. http://dx.doi.org/10.1023/A:1026377521890
[30] K. Dahan, M. Fennel and N. B. Kumar, “Lycopene in the Prevention of Prostrate Cancer,” Journal of Social Integration and Oncology, Vol. 6, 2008, pp. 29-36.
[31] D. S. Oliveira, A. L. Lobato, S. M. R. Ribeiro, N. M. C. Santana, J. B. P. Chaves and H. M. P. Ana, “Carotenoids and Vitamin C during Handling and Distribution of Guava (Psidium guajava L.), Mango (Mangifera indica L.), and Papaya (Carica papaya L.) at Commercial Restaurants,” Journal of Agricultural and Food Chemistry, Vol. 58, No. 10, 2010, pp. 6166-6172. http://dx.doi.org/10.1021/jf903734x
[32] J. C. Wiggins, M. Goyal, B. L. Wharram and R. C. Wiggins, “Antioxidant Ceruloplasmin Is Expressed by Glomerular Parietal Epithelial Cells and Secreted into Urine in Association with Glomerular Aging and High-Calorie Diet,” Journal of American Society of Nephrology, Vol. 17, 2006, pp. 1382-1387.
[33] Y. S. Park, K. Suzuki, S. Mumby, N. Taniguchi and J. M. C. Gutteridge, “Antioxidant Binding of Ceruloplasmin to Myeloperoxidase: Myeloperoxidase Is Inhibited, but Oxidase, Peroxidase and Immunoreactive Properties of Ceruloplasmin Remain Intact,” Free Radical Research, Vol. 33, 2000, pp. 261-265.
[34] M. Sattler, S. Verma, G. Shrikhande, et al., “The BCR/ABL Tryrosine Kinase Induces Production of Reactive Oxygen Species in Hematopoietic Cells,” The Journal of Biological Chemistry, Vol. 275, No. 32, 2000, pp. 24273-24278.

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.